| Unique ID issued by UMIN | UMIN000057766 |
|---|---|
| Receipt number | R000065731 |
| Scientific Title | The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery |
| Date of disclosure of the study information | 2025/05/03 |
| Last modified on | 2025/11/06 21:47:58 |
The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery
EU-SCT1
The impact of differences in femoral implant design on the peri-implant bone mineral density, muscle strength, and activity level in total hip replacement surgery
EU-SCT1
| Japan |
osteoarthritis of the hip
| Orthopedics |
Others
NO
Total hip arthroplasty (THA) is an important treatment for relieving the pain and restoring range of motion limitations caused by hip osteoarthritis and improving patient's quality of life. With an increasing number of procedures being performed due to the aging population, the design of the femoral implant (stem) has become a focal point as a significant factor influencing postoperative outcomes. This study aims to generate evidence that will improve clinical outcomes following THA. It will achieve this by comparing the effects of the shape and surface treatment of the Insignia stem and the Accolade 2 stem on several key factors: initial fixation and mid-term stability of the stem, stem subsidence, bone response around the femoral stem, changes in bone mineral density in the femur, and clinical evaluation. Furthermore, this study intends to provide valuable information for preoperative planning and stem selection in clinical practice. We anticipate that the analysis of radiological evaluations and clinical indicators from multiple perspectives, through randomized trials, will contribute to further advancements in THA outcomes.
Efficacy
The primary outcome is the change in periprosthetic bone mineral density, measured quantitatively at 1, 2, and 5 years postoperatively using bone mineral density testing around the stem. This change will be calculated relative to the bone mineral density around the stem measured on the 7th day after THA surgery, and the effect of differences in stem design on these changes in periprosthetic bone mineral density will be compared between the two groups.
Secondary outcomes will compare the two groups regarding the impact of stem design differences on radiological evaluations (plain radiographs and CT scans) and on pre- and post-operative clinical evaluations, including muscle strength, patient-reported outcomes, activity level, and other relevant factors.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
YES
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
| Device,equipment |
The Insignia Stem utilizes a tapered wedge geometry for fixation within the proximal femur. A key design feature is its substantial proximal volume aimed at maximizing metaphyseal fill in lateral view. The stem incorporates a full hydroxyapatite (HA) coating.
The Accolade 2 Stem utilizes a tapered wedge geometry for fixation within the proximal femur. A key design feature is its flat shape in lateral view. The stem incorporates a 3D porous coating in proximal part.
| 50 | years-old | <= |
| 80 | years-old | > |
Female
1) Undergoing primary unilateral or bilateral (simultaneous or staged) Total Hip Arthroplasty (THA) at Ehime University Hospital.
2) Diagnosis of advanced to end-stage osteoarthritis of the hip, confirmed radiographically.
3) Presence of hip pain causing functional limitations in activities of daily living (ADLs).
4) Suitable candidacy for either the Insignia Stem or the Accolade II Stem, confirmed by pre-operative CT-based 3D templating.
5) Ability and willingness to provide written informed consent.
1) Patients unable to achieve outdoor ambulation, even with the assistance of walking aids (e.g., canes, walkers).
2) Patients with cognitive impairment precluding informed consent, or those otherwise unable to express intention to participate; additionally, any patient deemed unsuitable for study inclusion by the principal investigator or sub-investigators.
3) Patients diagnosed with osteoarthritis of the hip secondary to infection or trauma, idiopathic osteonecrosis of the femoral head (ONFH), or high-grade developmental dysplasia of the hip (Crowe type III or IV).
4) Patients assessed by the attending physician, based on pre-operative CT planning, as having poor suitability for femoral implant fixation due to anatomical or bone quality concerns.
74
| 1st name | Masaki |
| Middle name | |
| Last name | Takao |
Ehime University Graduate School of Medicine
Department of Orthopaedic Surgery
791-0295
454 Shitsukawa, Toon, Ehime, 791-0295, Japan
0899605343
takao.masaki.ti@ehime-u.ac.jp
| 1st name | Tatsuhiko |
| Middle name | |
| Last name | Kutsuna |
Ehime University Graduate School of Medicine
Department of Orthopaedic Surgery
791-0295
454 Shitsukawa, Toon, Ehime, 791-0295, Japan
0899605343
kutsuna.tatsuhiko.bh@ehime-u.ac.jp
Ehime University
none
Self funding
Institutional Review Board,Ehime University Hospital
454 Shitsukawa, Toon, Ehime
089-960-5172
rinri@m.ehime-u.ac.jp
NO
| 2025 | Year | 05 | Month | 03 | Day |
Unpublished
Open public recruiting
| 2025 | Year | 03 | Month | 06 | Day |
| 2025 | Year | 03 | Month | 25 | Day |
| 2025 | Year | 04 | Month | 21 | Day |
| 2032 | Year | 12 | Month | 31 | Day |
| 2033 | Year | 12 | Month | 31 | Day |
| 2025 | Year | 05 | Month | 03 | Day |
| 2025 | Year | 11 | Month | 06 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000065731